167,000 fresh Covishield doses arrive in Delhi for 18-44 age group: AAP MLA

On Friday, a total of 77,345 doses were administered in Delhi, out of which 62,230 were first doses and 15,115 second doses.

Coronavirus vaccine
Photo: Bloomberg
Press Trust of India New Delhi
2 min read Last Updated : Jun 19 2021 | 7:36 PM IST

With Delhi receiving fresh stock of 1,67,000 Covishield doses for people in the 18-44 age group, the total number of Covid vaccines available for the group has now gone up to 2,95,000, senior AAP leader and MLA Atishi said on Saturday.

Presenting a daily vaccination bulletin, the MLA from Kalkaji said Delhi now has 2,58,000 doses of Covishield and 37,000 doses of Covaxin available for the 18-44 age group.

"We have seen that the speed of the vaccination drive goes up with the availability of vaccines for the 18-44 age group, and goes down as soon as they are on the verge of running out of stock. Here, we are happy to share that Delhi on Friday received 1,67,000 Covishield doses for the age group," said Atishi.

"The present stock of Covishield and Covaxin doses would last for 14 and two days, respectively. So we urge more youngsters to book their slot on the CoWin app and get themselves inoculated," she added.

Talking about the vaccine stock available for people above 45 years, Atishi said there are almost 8,50,000 Covid doses in the present stock, of which 7,65,000 are Covishield and 80,000 Covaxin.

"While the Covaxin stock is good enough to last for six days, the Covishield stock would last for another 58 days," she said.

On Friday, a total of 77,345 doses were administered in Delhi, out of which 62,230 were first doses and 15,115 second doses.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 19 2021 | 7:29 PM IST

Next Story